Similar articles

• A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.

  Sunderland GT, Belch JJ, Sturrock RD, Forbes CD, McKay AJ. Sunderland GT, et al. Clin Rheumatol. 1988 Mar;7(1):46-9. doi: 10.1007/BF02284056. Clin Rheumatol. 1988. PMID: 3044673 Clinical Trial.
• An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.

  Holti G. Holti G. J Int Med Res. 1979;7(6):473-83. doi: 10.1177/030006057900700601. J Int Med Res. 1979. PMID: 391622 Clinical Trial.
• The effects of vasodilator agents and of indirect heating in Raynaud's disease.

  Hansteen V. Hansteen V. Scand J Clin Lab Invest Suppl. 1973;128:211-2. Scand J Clin Lab Invest Suppl. 1973. PMID: 4764583 No abstract available.
• [The vasoprostan treatment of patients with Raynaud's syndrome].

  Alekperov RT, Mach ES, Guseva NG. Alekperov RT, et al. Ter Arkh. 1997;69(8):22-3. Ter Arkh. 1997. PMID: 9381386 Review. Russian. No abstract available.
• Raynaud's (primary).

  Pope J. Pope J. Clin Evid. 2003 Dec;(10):1444-53. Clin Evid. 2003. Update in: Clin Evid. 2004 Dec;(12):1725-34. PMID: 15555156 Updated. Review. No abstract available.